ACCUTAR BIOTECHNOLOGY INC.

Profile

Company Names

ACCUTAR BIOTECHNOLOGY INC.

Addresses

760 PARKSIDE AVENUE, SUITE 213, BROOKLYN, NY 11226

235 E 55TH ST. APT. 42A, NEW YORK, NY 10022

Phone Numbers

646-462-5083

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$76,452,191.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-12-04 
$28,452,239.00 
$28,452,239.00 
$0.00 
Equity 
2
2020-08-31 
$20,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2019-07-11 
$27,999,952.00 
$27,999,952.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JIE 
 
FAN 
EXECUTIVE OFFICER, DIRECTOR
ACCUTAR BIOTECHNOLOGY INC.   |  TIGER BIOTHERAPEUTICS INC.
WEI 
 
HE 
EXECUTIVE OFFICER
IVDIAGNOSTICS, INC.   |  IV DIAGNOSTICS, LLC   |  IVD LLC   |  ACCUTAR BIOTECHNOLOGY INC.
KE 
 
LIU 
EXECUTIVE OFFICER
ACCUTAR BIOTECHNOLOGY INC.
YIMIN 
 
QIAN 
EXECUTIVE OFFICER
ACCUTAR BIOTECHNOLOGY INC.
XIANGYAN 
 
SUN 
EXECUTIVE OFFICER
ACCUTAR BIOTECHNOLOGY INC.
QUAN 
 
ZHOU 
DIRECTOR
IDG-ACCEL CHINA CAPITAL II L.P.   |  IDG-ACCEL CHINA GROWTH FUND III L.P.   |  WUPIMA INC   |  ORIGENE TECHNOLOGIES, INC.   |  JENAVALVE TECHNOLOGY INC   |  BIONANO GENOMICS, INC   |  ACCUTAR BIOTECHNOLOGY INC.   |  IDG BREYER CAPITAL FUND L.P.   |  IDG CAPITAL PROJECT FUND II, L.P.   |  TIGER BIOTHERAPEUTICS INC.
LONG 
 
ZHU 
DIRECTOR
ACCUTAR BIOTECHNOLOGY INC.
LING 
 
ZOU 
DIRECTOR
ACCUTAR BIOTECHNOLOGY INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-04 
2020-09-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-31 
2019-08-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#